← Back
$VNDA All transactions

Vanda Pharmaceuticals Inc.

A

$ Value

$0

Shares

125,000

Price

$0

Filed

Feb 19

Insider

Name

Birznieks Gunther

Title

SVP, Business Development

CIK

0001702031

Roles

Officer

Transaction Details

Transaction Date

2026-02-18

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

536,628

Footnotes

Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2027, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Filing Info

Accession No.

0001193125-26-059784

Form Type

4

Issuer CIK

0001347178

Birznieks Gunther's History

Date Ticker Type Value
2026-03-02 VNDA $351K
2026-02-18 VNDA A $0

Other Insiders at VNDA (90d)

Insider Bought Sold Last
Polymeropoulos Mihael Hristos
President and CEO
$1.3M 2026-03-02
Birznieks Gunther
SVP, Business Development
$351K 2026-03-02
Williams Timothy
SVP & General Counsel
$351K 2026-03-02
Wijkstrom Joakim
SVP, Chief Marketing Officer
$255K 2026-03-02
Moran Kevin Patrick
SVP, CFO & Treasurer
$351K 2026-03-02
Honore Tage $241K 2026-02-23